heron therapeutics inc (HRTX:NASDAQ CM)
Barry D. Quart Pharm.D.
Chief Executive Officer and Director, Heron Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 21 board members in 3 different organizations across 7 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Barry D. Quart, Pharm.D., has been the Chief Executive Officer of Heron Therapeutics, Inc. since May 2, 2013. Dr. Quart serves as the Scientific Advisor of Napo Pharmaceuticals, Inc. He served as the Chief Executive Officer and President of Ardea Biosciences, Inc. since December 21, 2006, which was acquired by AstraZeneca PLC in June 2012. He served as General Manager for Americas Region, Kodak's Business Solutions and Services of Eastman Kodak Co. He served as the ...
123 Saginaw DrivePhone: 650-366-2626
Redwood City, California 94063
Board Members Memberships*
Former Chief Executive Officer, President and Executive Director
Director, Member of Audit Committee and Member of Compensation Committee
Chief Executive Officer and Director
University of California-San Francisco
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Olivier Brandicourt||Chief Executive Officer and Director|
|Dov Tamarkin Ph.D.||Co-Founder, Chief Executive Officer and Director|
Foamix Pharmaceuticals Ltd.
|$320.3K||Compensation as of Fiscal Year 2014.|